Boosting the level of a molecule called miR-29b in acute myeloid leukemia cells can reverse gene changes that trap the cells in an immature, fast growing state of development. The study shows how the miR reactivates silenced genes, enabling the leukemic cells to mature, an important step that precedes their death. The findings suggest that miR-29 could be a potent treatment for AML.